Birdwatch Note Rating
2023-11-18 03:21:20 UTC - HELPFUL
Rated by Participant: BF52D38A2D1B3FD7AEEA3F4C1C9C0625A3DD72135C962D7A280097D73E9DA266
Participant Details
Original Note:
In the trial the effectiveness of the vaccine against severe RSV disease in babies was 81.8%. The clinical trial efficacy & safety data is publicly available. The available data are insufficient to establish a causal relationship between preterm birth & the vaccine https://www.fda.gov/news-events/press-announcements/fda-approves-first-vaccine-pregnant-individuals-prevent-rsv-infants https://www.nejm.org/doi/10.1056/NEJMoa2216480 https://www.fda.gov/media/169361/download
All Note Details